Structure and properties of members of the hGH family: A review

Endocrine Journal

Volumn 47, Issue SUPPL., 2000, Pages

  Lewis, Urban J ^a   Sinha, Yagya N ^a   Lewis, Geoffrey P ^b  

^a Univ of California Santa Barbara ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes; Growth hormone; Retinopathy; Variants

Indexed keywords

HUMAN GROWTH HORMONE;

DIABETIC RETINOPATHY; DISULFIDE BOND; GEL ELECTROPHORESIS; GLYCOSYLATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOREACTIVITY; INSULIN RESISTANCE; ISOELECTRIC FOCUSING; PROTEIN FAMILY; RETINA BLOOD VESSEL; REVIEW;

EID: 0034052502     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.47.supplmarch_s1     Document Type: Review

References (35)

1. 44-191, a reportedly diabetogenic fragment of hGH, circulates in human blood: Measurement with a radioimmunoassay. J Clin Endocrinol Metab 78: 1411-1418.
2. Lewis UJ, Peterson SM, Bonewals LF, Seavey BK, VanderLaan WP (1977) An interchain disulfide dimer of human growth hormone. J Biol Chem 252: 3697-3702.
3. Haro LS, Lewis UJ, Garcia M, Bustamante J, Martinez AO, Ling NC (1996) Glycosylated human growth hormone (hGH): A novel 24kDa hGH-N variant. Biochem Biophys Res Commun 228: 549-556.
4. Lewis UJ, Dunn JT, Bonewald LF, Seavey BK, VanderLaan WP (1978) A naturally occurring structural variant of human growth hormone. J Biol Chem 253: 2679-2687.
5. Lewis UJ, Bonewald LF, Lewis LJ (1980) The 20,000-dalton variant of human growth hormone: Location of the amino acid deletions. Biochem Biophys Res Commun 92: 511-516.
6. Wallis M (1980) Growth hormone: deletions in the protein and introns in the gene. Nature 284: 512.
7. Frigeri LG, Peterson SM, Lewis UJ (1979) The 20,000-dalton structural variant of human growth hormone: Lack of some early insulin-like effects. Biochem Biophys Res Commun 91: 778-782.
8. Tinsley FC, Grinnan EL, Baker SH, Powell JG, Bemis KG, Sharr CJ (1986) The 20,000 dalton structural variant of recombinant DNA-derived methionyl human growth hormone has early insulin-like effects in hypophysectomized rats. Biochem Biophys Res Commun 138: 342-348.
9. Lewis UJ, Singh RNP, Tutwiler GF (1981) Hyperglycemic activity of the 20,000-dalton variant of human growth hormone. Endocrine Res Commun 8: 155-164.
10. Shaar CJ, Grinnan EL, Short WG, Powell JG, Bryan N, Bemis KG, Tinsley FC (1986) Hyperglycemic activity in dogs of recombinant DNA-derived 20,000 dalton variant of methionyl human growth hormone. Endocrine Res 12: 21-35.
11. Ader M, Agajanian T, Finegood DT, Bergman RN (1987) Recombinant deoxyribonucleic acid-derived 22k-and 20k-human growth hormone generates equivalent diabetogenic effects during chronic infusion in dogs. Endocrinology 120: 725-731.
12. Uchida H, Naito N, Asada N, Wada M, Ikeda M, Kobayashi H, Asanagi M, Mori K, Fujita Y, Konda K, Kusuhara N, Kamioka T, Nakashima K, Honjo M (1997) Secretion of authentic 20-kDa human growth hormone (20K hGH) in Escherichia coli and properties of the purified product. J Biotechnol 55: 101-112.
13. Hashimoto Y, Ikeda I, Ikeda M, Takahashi Y, Hosaka M, Uchida H, Kono N, Fuku H, Makino T, Honjo M (1999) Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone. J Immunol Methods in press.
14. Wada M, Uchida H, Ikeda M, Tsunekawa B, Naito N, Banba S, Tanaka E, Hashimoto Y, Honjo M (1998) The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma. Mol Endocrinol 12: 146-156.
15. Fujikawa T, Kaneko H, Hibasami H, Sakaguchi K, Alam KSM, Tanaka M, Nakashima K (1998) Inverse effects of 20 K and 22 K human growth hormones on the growth of T-47D human breast cancer cells in culture and in nude mice. Biochem Mol Biol International 46: 719-724.
16. Chasalow FI (1997) Molecular mechanisms of insulin resistance: Possible role of 20K hGH and IGF-2. Horm Res 48 (Suppl 2): p. 147 (Abstract).
17. Frigeri LG, Teguh C, Ling N, Wolff GL, Lewis UJ (1998) Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow AVY/A obese mice with amino-terminal peptides of human growth hormone. Endocrinology 122: 2940-2945.
18. Mondon CE, Reaven GM, Ling N, Lewis UJ, Frigeri LG (1988) Amino-terminal peptide of growth hormone enhances insulin action in normal rats. Endocrinology 123: 827-833.
19. Stevenson RW, Stebbing N, Rudman CG, Williams PE, Cherrington AD (1987) The synthetic 32-46 fragment of human growth hormone increases insulin and glucagon levels in the conscious dog. Metabolism 36: 400-404.
20. Dubey AK, Bodkin NL, Lewis UJ, Hansen BC (1987) The synthetic human growth hormone fragment (hGHF) enhances insulin-stimulated clearance of blood glucose in rhesus monkey. Diabetes 36 (suppl) 192A (Abstract 730).
21. Greenberg E (1965) Growth hormone and diabetes mellitus. Diabetes 14: 43-45.
22. Levine R, Luft R (1964) The relationship between the growth and diabetogenic effects of the so-called growth hormone of the anterior pituitary. Diabetes 13: 651-655.
23. Campbell J (1954) Diabetogenic actions of growth hormone. In: Smith RW, Gaebler OH, Long CNH (eds) The Hypophyseal Growth Hormone, Nature and Actions. The Blakiston Division, McGraw-Hill Book Co., Inc., New York, 270-285.
24. Lewis UJ, Singh RNP, Lindsey TT, Seavey BK, Lambert TH (1974) Enzymatically modified growth hormones and the diabetogenic activity of human growth hormone. In: Rati S (ed) Advances in Human Growth Hormone Research. DHEW publication no. 74-612, US Government Printing Office, Washington DC, pp 349-363.
25. 44-191) with enhanced diabetogenic acitivity. Mol Cell Endocrinol 78: 45-54.
26. Frigeri LG, Wolff GL, Robel G (1983) Impairment of glucose tolerance in yellow (Avy/A) (BALB/c x VY) F-1 hybrid mice by hyperglycemic peptide(s) from human pituitary glands. Endocrinology 113: 2097-2105.
27. Salem MAM, Wolff GL (1989) Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice. Proc Soc Exptl Biol Med 191: 113-123.
28. Warner MD, Sinha YN, Peabody CA (1993) Growth hormone and prolactin variants in normal subjects. Horm Metab Res 25: 425-429.
29. CoNg LL, Chasalow FI, Escobar O, Blethen SL (1999) Growth hormone isoforms in a girl with gigantism. J Ped Endocrinol Metab 12: 99-106.
30. Lundbæk K, Jensen VA, Olsen TS, Ørskov H, Christensen NJ, Johansen K, Hansen AP, Østerby R (1970) Diabetes, diabetic angiopathy, and growth hormone. The Lancet, July 18: 131-133.
31. Hausler HR, Sibay TM, Campbell J (1964) Retinopathy in a dog following diabetes induced by growth hormone. Diabetes 13: 122-126.
32. Singh RNP, Seavey BK, Lewis LJ, Lewis UJ (1983) Human growth hormone peptide 1-43: Isolation from pituitary glands. J Prot Chem 2: 425-436.
33. Rowlinson SW, Waters MJ, Lewis UJ, Barnard R (1996) Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems. Endocrinology 137: 90-95.
34. Salem MAM (1988) Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats. Endocrinology 123: 1565-1576.
35. 1-43), monoclonal antibodies in an ELISA. J Immunological Methods 215: 179-185.